Latest Advisory

  • FDA Advisory No. 2016-032 || Selected Parabens Declared as Banned Ingredients that may be Contained in Cosmetic Products

    FDA Advisory No. 2016-032 || Selected Parabens Declared as Banned Ingredients that may be Contained in Cosmetic Products

    Read more

  • FDA Advisory No. 2016-031 || Postponement of FDA Academy Training Schedule for the Month of April and May 2016

    FDA Advisory No. 2016-031 || Postponement of FDA Academy Training Schedule for the Month of April and May 2016

    Read more

  • FDA Advisory No. 2016-030 || Product Recall of All Sterile Veterinary Drug Products Manufactured by Belman Laboratories from 10 August 2015 up to 15 December 2015

    FDA Advisory No. 2016-030 || Product Recall of All Sterile Veterinary Drug Products Manufactured by Belman Laboratories from 10 August 2015 up to 15 December 2015

    Read more

  • FDA Advisory No. 2016-029 || Product Recall of All Sterile Veterinary Drug Products Manufactured by Enson Laboratories, Inc. from 01 January 2015 up to 18 December 2015

    FDA Advisory No. 2016-029 || Product Recall of All Sterile Veterinary Drug Products Manufactured by Enson Laboratories, Inc. from 01 January 2015 up to 18 December 2015

    Read more

  • FDA Advisory No. 2016-028 || Product Recall of Batch Number EZ6369 of Rifampicin + Isoniazid + Pyrazinamide + Ethambutol HCl 150 mg/ 75 mg/ 400 mg/ 275 mg Film-Coated Tablet (Onecure)

    FDA Advisory No. 2016-028 || Product Recall of Batch Number EZ6369 of Rifampicin + Isoniazid + Pyrazinamide + Ethambutol HCl 150 mg/ 75 mg/ 400 mg/ 275 mg Film-Coated Tablet (Onecure)

    Read more

Administrative Order No. 2015-0053

Implementing Guidelines on the Promotion and Marketing of Prescription Pharmaceutical Products and Medical Devices

I. RATIONALE/BACKGROUND

As provided by the 1987 Constitution, it is the State's policy to protect and promote the right to health of the people and instill health consciousness among them (Sec. 15, Art. II). This includes the adoption of an integrated and comprehensive approach to health development which shall endeavor to make essential goods, health and other social services available to all the people at affordable cost (Sec. 11, Art. XIII), as well as the establishment and maintenance of an effective food and drug regulatory system (Sec. 12, Art. XIII), among others.

 

to continue reading download the attachment...

Administrative Order 2016-0003

Guidelines on the Unified Licensing Requirements and Procedure of the Food and Drug Administration (FDA)

I. RATIONALE

The 1987 Philippine Constitution mandates the establishment of an effective food and drug regulatory system that is responsive to the country's health needs and problems.

Consistent with said constitutional provision, Congress passed landmark legislations, namely Republic Act (RA) No. 3720 (Food, Drugs and Devices and Cosmetics Act), as amended by RA No. 9711 (Food and Drug Administration Act of 2009), RA No. 10611 (Food Safety Act of 2013), and RA No. 9502 Universally Accessible Cheaper and Quality Medicine Act of 2008) mandating FDA to regulate establishments engaged in health products to ensure consumer safety, welfare protection, and fair practice

 

To continue reading download the attachment...

Administrative Order No. 2016-0008

Revised Rules and Regulations Governing the Generic Labeling Requirements of Drug Products for Human Use

I. RATIONALE

Article III, Section 7 of the 1987 Philippines Constitution declares that the state recognizes the right of the people to gain information on matters of public concern, such as those relating to health and health products.

 

To continue reading download attachment...

Attachments:
Download this file (ao2016-0008.pdf)ao2016-0008.pdf

Share Us on

Submit to FacebookSubmit to Google PlusSubmit to Twitter